Loading quotes...

Forecast

The analysts' average price target is €154.50 (0.00%). The median is €156.22 (+1.11%).

Buy	33
Hold	7
Sell	1

News Go to news feed

Agilent Technologies raises full-year outlook and beats quarterly results

Agilent Technologies raised its 2026 targets for adjusted earnings per share to $6.18–$6.21 and for revenue to up to $7.510 billion, significantly exceeding analyst expectations. In the most recent quarter, earnings per share rose 18.25% to $1.62 and revenue increased 8.06% to $1.878 billion, also clearly above the consensus. The outlook and the results drove the stock higher on heavy trading volume. » More on finanzen.net
Agilent Technologies targets China growth, lab automation and CDMO capacity expansion

Agilent said improving end markets, market-share gains and LC/GC replacement cycles are driving accelerated revenue growth, with China expected to be a mid- to high-single-digit long-term market. Management is prioritizing autonomous laboratories, AI-enabled instruments and software to expand testing demand and efficiency. The advanced therapeutics CDMO business grew 30% this quarter, with new Train C and D capacity set to roughly double site revenue over time, and reshoring orders represent a potential $300 million opportunity by 2030. » More on finance.yahoo.com
Agilent launches FDA-cleared S540MD scanner that holds 540 slides to speed digital pathology

Agilent introduced the FDA-cleared S540MD slide scanner in the US, capable of holding 540 slides with refillable racks and automated modes aimed at high-volume labs preparing for AI-assisted workflows. The device is a rebadged Hamamatsu NanoZoomer S540MD, with Agilent positioning its pathology and staining integration as the competitive edge; pricing, unit targets and revenue impact were not disclosed. The launch comes alongside a strong quarter and raised full-year non-GAAP guidance, though results benefited from tariff refunds and management expects slower core revenue growth in the next quarter. » More on finance.yahoo.com

Historical dividends Dividends

All dividend metrics All metrics

In 2026, Agilent Technologies has already paid €0.65 in dividends. The last payout was in July.

Financials

In the last quarter, Agilent Technologies had revenue of €1.63bn and net profit of €313.78m

(EUR)	July 2026	YoY
Revenue	1.63bn	6.99%
Gross profit	903.21m	12.88%
Net profit	313.78m	6.68%
EBITDA	467.21m	14.53%

Fundamentals

Metric	Value
Market capitalization	€43.56bn
Number of shares	281.97m
52-week high/low	€159.88 - €96.72
Dividend yield	0.42%
Dividends TTM	€0.65
Next dividend	€0.23
Beta	1.21
P/E ratio	34.00
PEG ratio	1.80
P/B ratio	6.63
P/S ratio	6.62

Company profile

Agilent Technologies, Inc. provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; vacuum pumps, and measurement technologies. The Diagnostics and Genomics segment provides arrays for DNA mutation detection, genotyping, gene copy number determination, identification of gene rearrangements, DNA methylation profiling, gene expression profiling, next generation sequencing, target enrichment and genetic data management, and interpretation support software; and produces synthesized oligonucleotide. It also offers immunohistochemistry in situ hybridization, and hematoxylin and eosin staining and special staining; consumables, and software for quality control analysis of nucleic acid samples; and reagents for use in turbidimetry and flow cytometry, as well as develops liquid-based pharmacodiagnostics. The Agilent CrossLab segment provides GC and LC columns, sample preparation products, custom chemistries, and laboratory instrument supplies; and startup, operational, training, compliance support, software as a service, asset management, and consultation services. The company markets its products through direct sales, distributors, resellers, manufacturer's representatives, and electronic commerce. Agilent Technologies, Inc. was incorporated in 1999 and is headquartered in Santa Clara, California.

Name	Agilent Technologies
CEO	Padraig McDonnell
Headquarters	Santa Clara, ca USA
Website	agilent.com
Sector	Health Care
Industry	Health Care Equipment & Supplies
IPO	18/11/1999
Employees	18,200